Inventor

MIDDLETON STEVEN A

US24 patents

⚠️ This page may combine multiple inventors who share the name “MIDDLETON STEVEN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MIDDLETON STEVEN A

JANSSEN PHARMACEUTICA NV

3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders

Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders

Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders

3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators

Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders

1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives

Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors

Piperazinyl substituted cyclohexane-1,4-diamines

Substituted isoindole-1,3-diones

Substituted pyrimidinyl oxime kinase inhibitors

Thiazolopyridine kinase inhibitors

Amino substituted pyridinyl methanone compounds useful in treating kinase disorders

Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds

Piperidinyl substituted cyclohexane-1,4-diamines

Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors

ORTHO MCNEIL PHARM INC

Substituted triazole diamine derivatives as kinase inhibitors

Substituted triazole diamine derivatives as kinase inhibitors

ORTHO PHARMA CORP

Methods for identifying erythropoietin receptor binding protein

DELCO ELECTRONICS CORP

Method for wire bonding an aluminum wire to a lead of an electronics package

DELPHI TECH INC

Electronic module

XU GUOZHANG

Substituted pyrimidinyl oxime kinase inhibitors

HUANG SHENLIN

1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives

BATTISTA KATHLEEN

Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders

CONNOLLY PETER J

Bicyclic pyrimidine kinase inhibitors